Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 17;13(24):7700.
doi: 10.3390/jcm13247700.

Catheter Ablation in Atrial Fibrillation: Recent Advances

Affiliations
Review

Catheter Ablation in Atrial Fibrillation: Recent Advances

Sahib Singh et al. J Clin Med. .

Abstract

Atrial fibrillation (AF) is the leading cause of arrhythmia-related morbidity and mortality. Recurrent symptoms, hospitalizations, and cost burden to patients have necessitated treatments beyond antiarrhythmic drugs (AADs) for patients with AF. Catheter ablation has proven to be effective over medical therapy alone; however the recurrence rates for atrial tachyarrhythmias post-ablation remain significant, particularly in patients with persistent and long-standing persistent AF. Hence, new techniques for catheter ablation have arisen, such as non-thermal energy sources, novel catheters, electroanatomical mapping, and ablation of additional targets. In this review, we discuss the recent advances in the field of catheter ablation, including newer modalities for the prevention of adverse events and future perspectives.

Keywords: atrial fibrillation; catheter ablation; cryoballoon; mapping; pulsed field; radiofrequency.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Martin S.S., Aday A.W., Almarzooq Z.I., Anderson C.A., Arora P., Avery C.L., Baker-Smith C.M., Gibbs B.B., Beaton A.Z., Boehme A.K., et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data from the American Heart Association. Circulation. 2024;149:e347–e913. doi: 10.1161/CIR.0000000000001209. Erratum in Circulation 2024, 149, e1164. - DOI - PubMed
    1. Zafeiropoulos S., Doundoulakis I., Bekiaridou A., Farmakis I.T., Papadopoulos G.E., Coleman K.M., Giannakoulas G., Zanos S., Tsiachris D., Duru F., et al. Rhythm vs. Rate Control Strategy for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. Pt 1JACC Clin. Electrophysiol. 2024;10:1395–1405. doi: 10.1016/j.jacep.2024.03.006. - DOI - PubMed
    1. Kanagaratnam P., McCready J., Tayebjee M., Shepherd E., Sasikaran T., Todd D., Johnson N., Kyriacou A., Hayat S., Hobson N.A., et al. Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: A prospective, randomized, multi-centre, open label trial. Europace. 2023;25:863–872. doi: 10.1093/europace/euac253. - DOI - PMC - PubMed
    1. Schwennesen H.T., Andrade J.G., Wood K.A., Piccini J.P. Ablation to Reduce Atrial Fibrillation Burden and Improve Outcomes: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2023;82:1039–1050. doi: 10.1016/j.jacc.2023.06.029. - DOI - PMC - PubMed
    1. Al-Kaisey A.M., Parameswaran R., Bryant C., Anderson R.D., Hawson J., Chieng D., Segan L., Voskoboinik A., Sugumar H., Wong G.R., et al. Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A Randomized Clinical Trial. JAMA. 2023;330:925–933. doi: 10.1001/jama.2023.14685. - DOI - PMC - PubMed

LinkOut - more resources